Singapore markets close in 28 minutes

SIGA Technologies, Inc. (SIGA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.75+0.25 (+3.33%)
At close: 04:00PM EDT
7.74 -0.01 (-0.13%)
After hours: 06:26PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.50
Open7.61
Bid7.73 x 100
Ask7.77 x 200
Day's range7.13 - 7.86
52-week range4.22 - 10.83
Volume1,733,039
Avg. volume954,367
Market cap551.199M
Beta (5Y monthly)0.95
PE ratio (TTM)8.16
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date25 Mar 2024
1y target estN/A
All
News
  • GlobeNewswire

    SIGA Reports Financial Results for Three Months Ended March 31, 2024

    Generated Product Sales of $24 Million and Pre-tax Operating Income of $11 MillionCorporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2024. “SIGA delivered strong results in the first quarter, with product revenues of $24 million and pre-tax operating income of $11 million, both up over the comp

  • GlobeNewswire

    SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results

    NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, May 7, 2024. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at www.siga.com under the 'Even

  • GlobeNewswire

    SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®

    NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious disease, announced today that it entered into an amendment to its international promotion agreement with Meridian Medical Technologies, Inc. (Meridian). Effective June 1, SIGA will drive international promotion activities for oral TPOXX® while maintaining its contractual relationship with Meridian to maintain continuity for key c